In acute myeloid leukemia (AML), ALKBH5 was positively regulated by KDM4C and the high level of ALKBH5 increased the stability of AXL (AXL receptor tyrosine kinase), thus promoting leukemia stem cells (30). Here, KDM4C is linked to acute myeloid leukemia.